UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Trend and treatment patterns of aplastic anemia in Korea, pure red cell aplasia and myelodysplastic syndrome in Korea: a nation-wide analysis

International journal of hematology, 2017-10, Vol.106 (4), p.500-507

2017

Volltextzugriff (PDF)

Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study

Haematologica (Roma), 2016-06, Vol.101 (6), p.717-723

2016

Volltextzugriff (PDF)

High level of pre-treatment C-reactive protein to albumin ratio predicts inferior prognosis in diffuse large B-cell lymphoma

Scientific reports, 2021-01, Vol.11 (1), p.2674-2674, Article 2674

2021

Volltextzugriff (PDF)

Survey of Opioid Risk Tool Among Cancer Patients Receiving Opioid Analgesics

Journal of Korean Medical Science, 2022, 37(23), , pp.1-11

2022

Volltextzugriff (PDF)

Pretreatment C-reactive protein-to-albumin ratio predicts clinical outcomes in patients with peripheral T-cell lymphoma

International journal of hematology, 2023-02, Vol.117 (2), p.216-224

2023

Volltextzugriff (PDF)

The efficacy of pemetrexed as a third- or fourth-line therapy and the significance of thymidylate synthase expression in patients with advanced non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2010-09, Vol.69 (3), p.323-329

2010

Volltextzugriff (PDF)

Change of health-related profiles after Imatinib cessation in chronic phase chronic myeloid leukemia patients

Leukemia & lymphoma, 2016-02, Vol.57 (2), p.341-347

2016

Volltextzugriff (PDF)

Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild‐type nonsmall cell lung cancer treated with EGFR‐tyrosine kinase inhibitors

Cancer, 2011-01, Vol.117 (1), p.143-151

2011

Volltextzugriff (PDF)

Single cell proteogenomic sequencing identifies a relapse‐fated AML subclone carrying FLT3‐ITD with CN‐LOH at chr13q

EJHaem, 2022-05, Vol.3 (2), p.426-433

2022

Volltextzugriff (PDF)

High-Dose Ifosfamide as Second- or Third-Line Chemotherapy in Refractory Bone and Soft Tissue Sarcoma Patients

Oncology, 2011-01, Vol.80 (3-4), p.257-261

2011

Volltextzugriff (PDF)

Lenalidomide for anemia correction in lower-risk del(5q) myelodysplastic syndrome patients of Asian ethnicity

Blood Research, 2021, 56(2), , pp.102-108

2021

Volltextzugriff (PDF)

Comparison of Therapeutic Outcomes Between Surgical Resection Followed By R-CHOP and R-CHOP Alone for Localized Primary Intestinal Diffuse Large B-cell Lymphoma

American journal of clinical oncology, 2014-04, Vol.37 (2), p.182-187

2014

Volltextzugriff (PDF)

Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)

Cancer chemotherapy and pharmacology, 2011-09, Vol.68 (3), p.753-761

2011

Volltextzugriff (PDF)

Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis

Cancer communications (London, England), 2021-03, Vol.41 (3), p.275-278

2021

Volltextzugriff (PDF)

Irinotecan monotherapy as second-line treatment in advanced pancreatic cancer

Cancer chemotherapy and pharmacology, 2009-05, Vol.63 (6), p.1141-1145

2009

Volltextzugriff (PDF)

Excision repair cross‐complementation group 1 (ERCC1) expression in advanced urothelial carcinoma patients receiving cisplatin‐based chemotherapy

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2010-12, Vol.118 (12), p.941-948

2010

Volltextzugriff (PDF)

Anti-erythropoietin and anti-thrombopoietin antibodies induced after administration of recombinant human erythropoietin

International immunopharmacology, 2011-12, Vol.11 (12), p.2237-2241

2011

Volltextzugriff (PDF)

Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer

Breast cancer research and treatment, 2009-11, Vol.118 (1), p.89-97

2009

Volltextzugriff (PDF)

Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX

Cancer chemotherapy and pharmacology, 2011-08, Vol.68 (2), p.317-323

2011

Volltextzugriff (PDF)

Can upfront systemic chemotherapy replace stereotactic radiosurgery or whole brain radiotherapy in the treatment of non-small cell lung cancer patients with asymptomatic brain metastases?

Lung cancer (Amsterdam, Netherlands), 2010-05, Vol.68 (2), p.258-263

2010

Volltextzugriff (PDF)

Outcomes of third-line docetaxel-based chemotherapy in advanced gastric cancer who failed previous oxaliplatin-based and irinotecan-based chemotherapies

Cancer Research and Treatment, 2012, 44(4), , pp.235-241

2012

Volltextzugriff (PDF)

A Rare Splicing Mutation in the PROS1 Gene of a Korean Patient with Type I Hereditary Protein S Deficiency

Annals of clinical and laboratory science, 2011-09, Vol.41 (4), p.397-400

2011

Volltextzugriff (PDF)

Prognostic role of insulin-like growth factor receptor-1 expression in small cell lung cancer

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2009-12, Vol.117 (12), p.861-869

2009

Volltextzugriff (PDF)

Rituximab-induced acute thrombocytopenia: a case report and review of the literature

Medical oncology (Northwood, London, England), 2009-03, Vol.26 (1), p.45-48

2009

Volltextzugriff (PDF)

1 – 25 von 465

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(399)
Mit Volltextzugriff
(338)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(241)
Life Sciences & Biomedicine
(209)
Humans
(152)
Female
(95)
Male
(81)
Animals
(69)
Biological And Medical Sciences
(56)
Middle Aged
(55)
Oncology
(55)
Mice
(53)
Medical Sciences
(49)
Adult
(47)
Radiology, Nuclear Medicine & Medical Imaging
(45)
Aged
(38)
Pharmacology & Pharmacy
(30)
Tumors
(30)
Medicine
(26)
Cell Line, Tumor
(25)
Medicine & Public Health
(25)
Original
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Trend and treatment patterns of aplastic anemia in Korea, pure red cell aplasia and myelodysplastic syndrome in Korea: a nation-wide analysis

Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study

High level of pre-treatment C-reactive protein to albumin ratio predicts inferior prognosis in diffuse large B-cell lymphoma

Survey of Opioid Risk Tool Among Cancer Patients Receiving Opioid Analgesics

Pretreatment C-reactive protein-to-albumin ratio predicts clinical outcomes in patients with peripheral T-cell lymphoma

The efficacy of pemetrexed as a third- or fourth-line therapy and the significance of thymidylate synthase expression in patients with advanced non-small cell lung cancer

Change of health-related profiles after Imatinib cessation in chronic phase chronic myeloid leukemia patients

Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild‐type nonsmall cell lung cancer treated with EGFR‐tyrosine kinase inhibitors

Single cell proteogenomic sequencing identifies a relapse‐fated AML subclone carrying FLT3‐ITD with CN‐LOH at chr13q

Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea

High-Dose Ifosfamide as Second- or Third-Line Chemotherapy in Refractory Bone and Soft Tissue Sarcoma Patients

Lenalidomide for anemia correction in lower-risk del(5q) myelodysplastic syndrome patients of Asian ethnicity

Comparison of Therapeutic Outcomes Between Surgical Resection Followed By R-CHOP and R-CHOP Alone for Localized Primary Intestinal Diffuse Large B-cell Lymphoma

Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)

Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis

Irinotecan monotherapy as second-line treatment in advanced pancreatic cancer

Excision repair cross‐complementation group 1 (ERCC1) expression in advanced urothelial carcinoma patients receiving cisplatin‐based chemotherapy

Anti-erythropoietin and anti-thrombopoietin antibodies induced after administration of recombinant human erythropoietin

Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer

Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX

Can upfront systemic chemotherapy replace stereotactic radiosurgery or whole brain radiotherapy in the treatment of non-small cell lung cancer patients with asymptomatic brain metastases?

Outcomes of third-line docetaxel-based chemotherapy in advanced gastric cancer who failed previous oxaliplatin-based and irinotecan-based chemotherapies

A Rare Splicing Mutation in the PROS1 Gene of a Korean Patient with Type I Hereditary Protein S Deficiency

Prognostic role of insulin-like growth factor receptor-1 expression in small cell lung cancer

Rituximab-induced acute thrombocytopenia: a case report and review of the literature

Suchergebnisse filtern